Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0077
-0.0022 (-22.38%)
Aug 22, 2025, 3:31 PM EDT
Curative Biotechnology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
7.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 105.45M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
Curative Biotechnology News
- 9 months ago - Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor - GlobeNewsWire
- 1 year ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors - GlobeNewsWire
- 1 year ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors - GlobeNewsWire
- 2 years ago - Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions - GlobeNewsWire
- 2 years ago - Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation - GlobeNewsWire
- 2 years ago - Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study - GlobeNewsWire
- 3 years ago - Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange - GlobeNewsWire
- 3 years ago - Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors - GlobeNewsWire